ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:639-640. doi:10.1016/j.athoracsur.2008.01.080
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anna Lassia Meyer
Stefan Fischer
Axel Haverich
Martin Strüber
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, A. L.
Right arrow Articles by Strüber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, A. L.
Right arrow Articles by Strüber, M.
Related Collections
Right arrow Mechanical Circulatory Assistance

Case Reports

Implantation of a Left Ventricular Assist Device in a Patient With Primary Antiphospholipid Syndrome

Anna Lassia Meyer, MDa, Christian Kuehn, MDa, Clemens Gras, MDb, Doris Malehsa, MDa, Christoph Bara, MDa, Stefan Fischer, MD, MSa, Axel Haverich, MDa, Martin Strüber, MDa,*

a Department of Cardiothoracic, Transplant, and Vascular Surgery, Hannover Medical School, Hannover, Germany
b Department of Anesthesia, Hannover Medical School, Hannover, Germany

Accepted for publication January 28, 2008.

* Address correspondence to Dr Strüber, Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany (Email: strueber.martin{at}mh-hannover.de).

The antiphospholipid syndrome is characterized by arterial and venous thrombosis and is associated with the presence of circulating antiphospholipid antibodies. Arterial thrombosis can result in myocardial infarction, which may potentially lead to end-stage heart failure. Here we report our anticoagulation protocol for patients with antiphospholipid syndrome that undergo axial-flow left ventricle assist devices (HeartMate II; Thoratec, Pleasanton, CA) implantation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.